ClassID:

170719

G01N2410/00 - CPC Classification

Classification description:

Assays, e.g. immunoassays or enzyme assays, involving peptides of less than 20 animo acids

Sub-classes:
Recent Application in this class:
#1
20250376711
2025-12-11

COMPOUND-DIAGNOSTIC MARKER FOR UTERINE BODY CANCER, METHOD FOR DETECTING ENZYMATIC ACTIVITY, METHOD FOR DIAGNOSIS OF UTERINE BODY CANCER, KIT COMPRISING THE COMPOUND, USES OF THE COMPOUND AND METHOD FOR THE TREATMENT OF UTERINE BODY CANCER

#2
20250346634
2025-11-13

CYCLIC PEPTIDES FOR TARGETING EPIDERMAL GROWTH FACTOR RECEPTOR AND MUTATIONS THEREOF FOR DRUG DELIVERY

#3
20250341517
2025-11-06

SWITCHING PEPTIDE, IMMUNOASSAY DEVICE COMPRISING SAME, AND IMMUNOASSAY METHOD USING SAME

#4
20250222119
2025-07-10

ENGINEERING OF MULTIFUNCTIONAL PEPTIDES FOR CONTROLLED DRUG DELIVERY

#5
20250155456
2025-05-15

ASSESSMENT METHODS AND DIAGNOSTIC KIT FOR PREDICTING SUICIDAL BEHAVIORS IN PATIENTS WITH DEPRESSIVE DISORDERS USING MULTIMODAL SERUM BIOMARKERS

#6
20250049883
2025-02-13

ANIMAL, FUNGAL AND MARINE SOURCES OF CGP AND INCREASED CGP CONCENTRATION FOR DISEASE MANAGEMENT AND FOR TREATMENT OF NON-NEUROLOGICAL AND/OR NEUROLOGICAL CONDITIONS

#7
20240319160
2024-09-26

Multiplexed Detection Of Toxins Using Graphene-Based Aptasensors

#8
20240209027
2024-06-27

PEPTIDE AND PEPTIDE-CONTAINING COMPOSITION

#9
20240003874
2024-01-04

Immunoassay controls and the use thereof

#10
20220107314
2022-04-07

Immunoassay controls and the use thereof

#11
20220034897
2022-02-03

Assays for detecting modified compounds

#12
20220033874
2022-02-03

Method of evaluating quality of dephosphorylation reagent and method of detecting target nucleic acid

#13
20210206808
2021-07-08

Peptoid compound and manufacturing method thereof, oligomer, pharmaceutical composition, and kit

#14
20210072240
2021-03-11

IGF-1 analysis, adjustment and disease management of non-neurological and/or neurological conditions

#15
20200256861
2020-08-13

IMMUNOSIGNATURING: A PATH TO EARLY DIAGNOSIS AND HEALTH MONITORING

#16
20200033332
2020-01-30

THIOLATED AROMATIC BLOCKING STRUCTURES FOR EAB BIOSENSORS

#17
20190345198
2019-11-14

Peptoid compound, and derivative, salt, preparation method and use thereof

#18
20190339264
2019-11-07

Immunoassay controls and the use thereof

#19
20190339246
2019-11-07

Multiplexed detection of toxins using graphene-based aptasensors

#20
20190338035
2019-11-07

Constructs targeting histone H3 peptide/MHC complexes and uses thereof

#21
20190169313
2019-06-06

Monoclonal antibody specific for gamma-glutamyl-l-epsilon-lysine for the monitoring of apoptosis

#22
20190162733
2019-05-30

Assays for detecting modified compounds

#23
20190085030
2019-03-21

D-enantiomeric peptides derived from D3 and use thereof

#24
20190056393
2019-02-21

METHOD OF DETECTING AUTO-ANTIBODIES FROM PATIENTS SUFFERING FROM RHEUMATOID ARTHRITIS, A PEPTIDE AND ASSAY KIT

#25
20180238900
2018-08-23

Method and kit for detecting glutathione

#26
20180237508
2018-08-23

Anti-CK8 antibodies for use in the treatment of colorectal cancers

#27
20170313744
2017-11-02

D-enantiomeric peptides derived from D3 and use thereof

#28
20170269078
2017-09-21

Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and assay kit

#29
20170101441
2017-04-13

Chemical and biochemical adducts as biomarkers for organophosphate exposure

#30
20160097784
2016-04-07

Detection of polymyxins

#31
20160097781
2016-04-07

METHOD FOR STRATIFYING A FEMALE SUBJECT FOR HORMONE REPLACEMENT THERAPY

#32
20160024206
2016-01-28

Methods for the Treatment and the Prognostic Assessment of Malignant Pleural Mesothelioma

#33
20150346219
2015-12-03

METHODS OF DETERMINING LEVELS OF FREE AMINO ACIDS AND DIPEPTIDES AND DIAGNOSING ALZHEIMER'S DISEASE

#34
20150346207
2015-12-03

Method for predicting the risk of getting cancer or diagnosing cancer in a subject

#35
20150307552
2015-10-29

NOVEL D-ENANTIOMERIC PEPTIDES DERIVED FROM D3 AND USE THEREOF

#36
20150153324
2015-06-04

Non-invasive method for measuring proliferation and differentiation state of cells by using magnetic resonance spectroscopy, and cell proliferation and differentiation marker for magnetic spectroscopy used therefor

#37
20150005471
2015-01-01

Assays for detecting modified compounds

#38
20140336069
2014-11-13

Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit

#39
20140080140
2014-03-20

Screening for neurotoxic amino acid associated with neurological disorders

#40
20120052481
2012-03-01

Assays for detecting modified compounds

#41
20110300161
2011-12-08

Methods for the treatment and the prognostic assessment of malignant pleural mesothelioma

#42
20110236931
2011-09-29

Chemical and biochemical adducts as biomarkers for organophosphate exposure

#43
20110195867
2011-08-11

METHOD OF ANALYZING PROTEIN MICROSTRUCTURE AND STRUCTURE FOR THE SAME

#44
20110195861
2011-08-11

Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit

#45
20110183424
2011-07-28

Screening for neurotoxic amino acid associated with neurological disorders

#46
20110097736
2011-04-28

Methods of determining levels of free amino acids and dipeptides and diagnosing Alzheimer's disease

#47
20100292147
2010-11-18

Identification of the hepcidin binding site on ferroportin

#48
20070292893
2007-12-20

Screening for neurotoxic amino acid associated with neurological disorders

#49
20070254315
2007-11-01

Screening for neurotoxic amino acid associated with neurological disorders

#50
20070184504
2007-08-09

Assay for anti-INGAP antibodies

#51
20070087380
2007-04-19

Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit

#52
20050042686
2005-02-24

Screening for neurotoxic amino acid associated with neurological disorders